Live Analyst Rating Changes 34764 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Ananda Ghosh
HC

Ananda Ghosh

H.C. Wainwright
Wall Street Analyst
★★☆☆☆
#2258
on 13Foresight · ranked by our own returns
54%
Success Rate
+0.4%
Average Return
20 of 37 calls profitable · +24.7% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 54% of Ananda Ghosh's ratings turned a profit when each position was held for 1 year — averaging +0.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

94 Buy 1 Hold 0 Sell
Ananda's Stock Coverage 11 ratings · 2026-09-27
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
ACAD
ACADIA Pharmaceuticals
 Sep 25, 2026 BUY Strong Buy
+74.1% avg upside
43 analysts
$33.00
59.61% Upside
 +0.0% ·
MAZE
Maze Therapeutics, Inc.
 Sep 22, 2026 BUY Strong Buy
+136.5% avg upside
13 analysts
$110.00
322.29% Upside
 -8.2% ·
IBIO
Ibio
 Sep 17, 2026 BUY Strong Buy
+398.9% avg upside
13 analysts
$7.00
488.23% Upside
 -4.8% ·
GPCR
Structure Therapeutics, Inc. Sponsored ADR
 Sep 09, 2026 BUY Strong Buy
+188.1% avg upside
17 analysts
$70.00
94.77% Upside
 -10.2% ·
PEPG
PepGen Inc.
 Sep 09, 2026 BUY Strong Buy
+309.7% avg upside
9 analysts
$20.00
672.27% Upside
 -9.5% ·
DYN
Dyne Therapeutics
 Aug 17, 2026 BUY Buy
+133.6% avg upside
31 analysts
$50.00
211.96% Upside
 -38.7% ·
PRQR
ProQR
 Aug 17, 2026 BUY Strong Buy
+573.4% avg upside
19 analysts
$12.00
627.36% Upside
 -5.2% ·
ANNX
Annexon Biosciences
 Aug 14, 2026 BUY Strong Buy
+287.1% avg upside
14 analysts
$14.00
284.70% Upside
 -20.0% ·
STOK
Stoke Therapeutics
 Aug 04, 2026 BUY Strong Buy
+65.0% avg upside
18 analysts
$50.00
101.53% Upside
 -21.7% ·
SKYE
Skye Bioscience
 May 21, 2026 BUY Strong Buy
+2754.3% avg upside
9 analysts
$160.00
9480.87% Upside
 -69.1% ·
IVA
Inventiva
 Jan 28, 2026 BUY Strong Buy
+382.7% avg upside
17 analysts
$24.00
612.15% Upside
 -44.7% ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Ananda Ghosh — Frequently Asked Questions
How accurate are Ananda Ghosh's stock ratings?
Based on the calls 13Foresight could measure, about 54% of Ananda's ratings were profitable over a one-year hold, with an average return of +0.4% per rating, or +24.7% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Ananda ranked on 13Foresight?
Ananda Ghosh is currently ranked #2258 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Ananda cover?
Ananda most recently has ratings on ACAD, MAZE, IBIO, GPCR, PEPG, DYN, PRQR, ANNX, STOK, SKYE, IVA. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.